mRNA |
KHS101 |
CTRPv2 |
pan-cancer |
AAC |
-0.081 |
0.04 |
mRNA |
tanespimycin:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.081 |
0.04 |
mRNA |
Mitomycin-C |
CTRPv2 |
pan-cancer |
AAC |
-0.072 |
0.04 |
mRNA |
RO-3306 |
GDSC1000 |
pan-cancer |
AAC |
-0.073 |
0.04 |
mRNA |
Bosutinib |
CTRPv2 |
pan-cancer |
AAC |
-0.074 |
0.04 |
mRNA |
etoposide |
GDSC1000 |
pan-cancer |
AAC |
-0.073 |
0.04 |
mRNA |
Gefitinib |
GDSC1000 |
pan-cancer |
AAC |
-0.069 |
0.04 |
mRNA |
selumetinib:GDC-0941 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.075 |
0.04 |
mRNA |
linifanib |
CTRPv2 |
pan-cancer |
AAC |
-0.075 |
0.05 |
mRNA |
Vandetanib |
CCLE |
pan-cancer |
AAC |
-0.091 |
0.05 |